1.24
1.59%
-0.02
시간 외 거래:
1.20
-0.04
-3.23%
Brainstorm Cell Therapeutics Inc (BCLI) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Research and Development |
43.40%
0.961
|
1.698 | 3.33 | 2.794 | 2.924 |
Operating Income/Loss |
48.50%
-2.474
|
-4.804 | -6.035 | -5.449 | -5.151 |
Income/Loss From Continuing Operations Before Tax |
39.03%
-3.401
|
-5.578 | -1.226 | -5.329 | -5.059 |
Income/Loss From Continuing Operations After Tax |
39.03%
-3.401
|
-5.578 | -1.226 | -5.329 | -5.059 |
Net Income/Loss
|
39.03%
-3.401
|
-5.578 | -1.226 | -5.329 | -5.059 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,195%
64.74
|
2.8204 | 44.25 | 39.70 | 36.74 |
Diluted Average Shares |
2,195%
64.74
|
2.8204 | 44.25 | 39.70 | 36.74 |
Basic Earnings Per Share |
54.55%
-0.05
|
-0.11 | -0.03 | -0.13 | -0.14 |
Diluted Earnings Per Share |
54.55%
-0.05
|
-0.11 | -0.03 | -0.13 | -0.14 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):